Product Information
CHLORPROMAZINE 200 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.8425 per EA under NDC 00904713361. Its NADAC has been published 227 times since Oct 27, 2021.
FDA first approved this application on Jan 17, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904713361
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
CHLORPROMAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213368FDA Approved
1/17/2020
TE Code
AB
On Market Since
1/27/2020
Pharmacological Classes
Price Statistics
The NADAC for CHLORPROMAZINE 200 MG TABLET has been published 227 times since Oct 27, 2021, and over the history we have for it it has declined 86.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8425 per EA |
|---|---|
| All-time high | $6.3685 (Nov 10, 2021) |
| All-time low | $0.8425 (Feb 18, 2026) |
| 52-week high | $1.2885 |
| 52-week low | $0.8425 |
| Median price | $1.4101 |
| Average price | $2.0983 |
| Largest weekly change | +59.5% (Nov 22, 2023) |
| Weeks tracked | 227 |
| Tracking since | Oct 27, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
-21.7%
3Y
-36.7%
5Y
N/A
All
-86.8%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHLORPROMAZINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLORPROMAZINE 200 MG TABLET, manufactured by Major Pharmaceuticals, is $0.8425 per EA (NDC 00904713361), effective Feb 25, 2026.
How has the price of CHLORPROMAZINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLORPROMAZINE 200 MG TABLET has declined 86.8%. It has been tracked across 227 weekly CMS publications since Oct 27, 2021.
What are the highest and lowest recorded NADAC prices for CHLORPROMAZINE 200 MG TABLET?
Since Oct 27, 2021, the NADAC for CHLORPROMAZINE 200 MG TABLET has ranged from a low of $0.8425 (Feb 18, 2026) to a high of $6.3685 (Nov 10, 2021), with a median of $1.4101 per EA.
Are there cheaper alternatives to CHLORPROMAZINE 200 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHLORPROMAZINE 200 MG TABLET, is $0.6853 per EA — about 19% below CHLORPROMAZINE 200 MG TABLET.
Who manufactures CHLORPROMAZINE 200 MG TABLET?
CHLORPROMAZINE 200 MG TABLET (NDC 00904713361) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.